Wedbush analyst issues UNDERPERFORM recommendation for NVDA on September 11, 2026 06:05PM ET. The previous analyst recommendation was Outperform.NVDA was trading at $219.415 at issue of the analyst recommendation.The overall...
UBS analyst issues NEUTRAL recommendation for CRM on September 11, 2026 01:19PM ET. The previous analyst recommendation was Neutral.CRM was trading at $249.2 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for CRM on September 11, 2026 01:33PM ET. The previous analyst recommendation was Buy.CRM was trading at $249.73 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues MARKET PERFORM recommendation for ADBE on September 11, 2026 12:05PM ET. The previous analyst recommendation was Market Perform.ADBE was trading at $248.83 at issue of the...
Evercore ISI analyst issues OUTPERFORM recommendation for OXY on September 11, 2026 11:59AM ET. The previous analyst recommendation was Outperform.OXY was trading at $61.16 at issue of the analyst recommendation.The...
UBS analyst issues BUY recommendation for ORCL on September 11, 2026 12:10PM ET. The previous analyst recommendation was Buy.ORCL was trading at $153.17 at issue of the analyst recommendation.The overall...
UBS analyst issues NEUTRAL recommendation for ADBE on September 11, 2026 12:10PM ET. The previous analyst recommendation was Neutral.ADBE was trading at $248.83 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues OUTPERFORM recommendation for ORCL on September 11, 2026 12:17PM ET. The previous analyst recommendation was Outperform.ORCL was trading at $153.17 at issue of the analyst recommendation.The...
Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for ORCL on September 11, 2026 11:20AM ET. The previous analyst recommendation was Overweight.ORCL was trading at $153.17 at issue of the analyst recommendation.The...
Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CVS on September 11, 2026 11:14AM ET. The previous analyst recommendation was Overweight.CVS was trading at $95.29 at issue of the analyst recommendation.The...
